ROLIMUS 5MG TABLETS| EVEROLIMUS USES & SIDE EFFECTS - PowerPoint PPT Presentation

About This Presentation
Title:

ROLIMUS 5MG TABLETS| EVEROLIMUS USES & SIDE EFFECTS

Description:

Rolimus 5mg is a derivative of Rapamycin (sirolimus) and works similarly to Rapamycin as an mTOR (mammalian target of rapamycin) inhibitor. – PowerPoint PPT presentation

Number of Views:24

less

Transcript and Presenter's Notes

Title: ROLIMUS 5MG TABLETS| EVEROLIMUS USES & SIDE EFFECTS


1
ROLIMUS 5MG TABLETS EVEROLIMUS USES SIDE
EFFECTS
  • Million Health Pharmaceuticals

2
DESCRIPTION
  • Rolimus 5mg is a derivative of Rapamycin
    (sirolimus) and works similarly to Rapamycin as
    an mTOR (mammalian target of rapamycin)
    inhibitor. It is normally used as an
    immunosuppressant to prevent rejection of organ
    transplants. 

3
Brain carcinoma
4
PRESCRIBING INFORMATION
  • Rolimus 5mg tablet are mainly indicated for the
    treatment of Renal carcinoma.Rolimus 5mg
    tablet are mainly indicated for the treatment of
    Breast carcinoma.Rolimus 5mg tablet are mainly
    indicated for the treatment of Brain
    carcinoma.Rolimus 5mg is also used in various
    advanced stage cancer in stomach, intestines or
    pancreas.

5
MECHANISM OF ACTION
  • Everolimus is an mTOR prohibitor, joints at high
    compatibility to FK506 binding protein 12, via
    producing drug complex which inhibits the
    specific of mTOR.This inhibition decreases the
    activity of effectors downstream, that may cause
    blockage of cell progression from G1 into S
    phase, subsequently causes cell growth arrest and
    apoptosis

6
ROLIMUS 5MG
7
PRODUCT DETAILS
  • Brand Rolimus Ingredients Everolimus Strengt
    h 5mgManufactured Cipla Ltd Package 10
    tablets 

8
PHARMACOKINETICS
  • PHARMACOKINETICS
  • ABSORPTION
  • The high plasma concentration time of Everolimus
    is 1 to 2 hours.The effect of food with Rolimus
    5mg that with heavy meal Reduction of systemic
    exposure to Rolimus 5mg10mg, and the high blood
    plasma concentration by 54.DISTRIBUTION
  • Rolimus 5mg human plasma protein bound with the
    range of 74.METABOLISM
  • The metabolism of Everolimus is occurred in
    liver, which is a substrate of CYP3A4.The
    metabolites of Everolimus Three monohydroxylated
    metabolite,

9
DOSAGE MANAGEMENT
  • In breast cancer, renal cell cancer, pancreatic
    cancer, Neuro endocrine cancer
  • The prescribed dosage is 10mg should be taken as
    a single dose.In Brain or intracranial cancer
  • The prescribed dosage of Rolimus  5mg is 4.5mg/m2
    orally as a single dose.In pediatric
  • The usual pediatric dosage of Rolimus 5mg in
    brain or intracranial tumor is 4.5mg/m2 should be
    taken orally as a single dose. 

10
PRECAUTIONS
  • Lymphomas
  • Increased exposure of skin cancers, patient may
    protect from UV lightSerious infections
  • Patients receiving Rolimus 5mg have high risk of
    acquiring various infections related to bacteria,
    virus, and fungi. Anti-microbial agents are
    preferred for the suspected patients.

11
SIDE EFFECTS
  • Hypersensitivity reactions Lymphomas other
    malignancy Serious infections Kidney graft
    thrombosis Hepatic artery thrombosis
    Nephrotoxicity Hyperlipemia Angioedema
    Interstitial lung disease Thrombocytopenia
    Male infertility Proteinuria New commencement
    of diabetes .

12
DRUG INTERACTION
  •  Rolimus 5mg interaction with strong inhibitor
    of CYP3A4, or P-gp, leads to cause decreasing the
    efflux of Everolimus and increase the plasma
    concentration of Everolimus. Combination
    of Rolimus 5mg with verapamil leads to increasing
    the plasma concentration of Everolimus.
    Combination of Rolimus 5mg with Atorvastatin or
    pravastatin causes rhabdomyolysis, due to
    increasing concentration of lipid lowering
    agents. Rolimus 5mg combination with strong
    CYP3A4 inducers, causes increasing the exposure
    of Everolimus. Concomitant use of Rolimus
    5mg with cyclosporine causes increasing the AUC
    level of Everolimus frequently.

13
CONTRAINDICATIONS
  • Some anaphylactic reaction occurs, if patients
    are contraindicated to the components present in
    the Rolimus 5mg tablet.

14
PREGNANCY
  • Pregnancy category C Rolimus 5mg is needed only
    by the patients after knowing the benefits to the
    mother outweighs the risk to fetus.

15
STORAGE
  • Rolimus 5mg tablet should be kept at 25CKeep
    the tablet away from moisture, heat and
    lightDispense only in original container.

16
MISSED DOSE
  • If patient failed to take a single dose, patients
    must consult with medical practitioner and follow
    the instructions given by them. Or the missed
    dose should be avoiding and follow the regular
    dosing schedule.

17
OVERDOSAGE
  • The over dosage of Everolimus is rarely occur, in
    case of over dosage patient must be provide with
    supportive measures. The acute toxicity of
    Everolimus over dosage should be monitored.

18
CONTACT US
  • PHONE NO91-9940472902
  • EMAILmillionhealthpharmaceuticals_at_gmail.com
  • WEBSITE URLhttps//millionpharma.com/rolimus-5-mg
    .php
Write a Comment
User Comments (0)
About PowerShow.com